Extracorporeal shock wave therapy (ESWT): An emerging treatment for peri-implantitis
Implants have captivated dental fraternity with their attractive benefits alongside patient satisfaction. Nonetheless, success rate depends on the durability of implants without persisting symptoms. Many challenges have yet been addressed by the clinicians, be it the patient selection criteria, impl...
Gespeichert in:
| Veröffentlicht in: | Medical hypotheses 2021-05, Vol.150, p.110565-110565, Article 110565 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 110565 |
|---|---|
| container_issue | |
| container_start_page | 110565 |
| container_title | Medical hypotheses |
| container_volume | 150 |
| creator | Elisetti, Nirupa |
| description | Implants have captivated dental fraternity with their attractive benefits alongside patient satisfaction. Nonetheless, success rate depends on the durability of implants without persisting symptoms. Many challenges have yet been addressed by the clinicians, be it the patient selection criteria, implant material susceptibility to microbial environment, procedural errors, etc. Evolving techniques focusing on these issues have resolved to a certain extent but research is still progressing towards perfection. ESWT presents itself as a non-invasive treatment modality beneficial both for the patients as well as the clinicians. Focusing on many of its benefits with its antimicrobial function to bone regeneration has attracted us. |
| doi_str_mv | 10.1016/j.mehy.2021.110565 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2508563790</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0306987721000839</els_id><sourcerecordid>2508563790</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-e1e7f2c659011035d5c540823b08c69a128132d07c9b8628b94dc1f06cf64d7f3</originalsourceid><addsrcrecordid>eNp9kLtOAzEQRS0EIuHxAxTIZSg2jO3Y3kU0URQeEhIFQZTWxjtLHLIPbAfI37NRgJJqmjNX9x5CzhgMGTB1uRxWuNgMOXA2ZAykknukz6TgCdda75M-CFBJlmrdI0chLAEgG4n0kPSE0FnGFO-T2fQr-tw2vm085isaFo19o5_5B9K4QJ-3GzqYPr3MLq7ouKZYoX919SuNHRwrrCMtG09b9C5xVbvK6-iiCyfkoMxXAU9_7jF5vpnOJnfJw-Pt_WT8kFghVUyQoS65VTKDrr6QhbRyBCkXc0itynLGUyZ4Adpm81TxdJ6NCstKULZUo0KX4pgMdrmtb97XGKKpXLC46npgsw6GS0il6rZCh_Idan0TgsfStN5Vud8YBmZr0yzN1qbZ2jQ7m93T-U_-el5h8ffyq68DrncAdis_HHoTrMPaYuE82miKxv2X_w0BXYUE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2508563790</pqid></control><display><type>article</type><title>Extracorporeal shock wave therapy (ESWT): An emerging treatment for peri-implantitis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Elisetti, Nirupa</creator><creatorcontrib>Elisetti, Nirupa</creatorcontrib><description>Implants have captivated dental fraternity with their attractive benefits alongside patient satisfaction. Nonetheless, success rate depends on the durability of implants without persisting symptoms. Many challenges have yet been addressed by the clinicians, be it the patient selection criteria, implant material susceptibility to microbial environment, procedural errors, etc. Evolving techniques focusing on these issues have resolved to a certain extent but research is still progressing towards perfection. ESWT presents itself as a non-invasive treatment modality beneficial both for the patients as well as the clinicians. Focusing on many of its benefits with its antimicrobial function to bone regeneration has attracted us.</description><identifier>ISSN: 0306-9877</identifier><identifier>EISSN: 1532-2777</identifier><identifier>DOI: 10.1016/j.mehy.2021.110565</identifier><identifier>PMID: 33799162</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Anti-Bacterial Agents ; Anti-Infective Agents ; Biofilms ; Bone Regeneration ; Dental Implants ; Extracorporeal Shockwave Therapy ; Growth factors ; Humans ; Implants ; Peri-Implantitis - therapy</subject><ispartof>Medical hypotheses, 2021-05, Vol.150, p.110565-110565, Article 110565</ispartof><rights>2021 Elsevier Ltd</rights><rights>Copyright © 2021 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-e1e7f2c659011035d5c540823b08c69a128132d07c9b8628b94dc1f06cf64d7f3</citedby><cites>FETCH-LOGICAL-c356t-e1e7f2c659011035d5c540823b08c69a128132d07c9b8628b94dc1f06cf64d7f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0306987721000839$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33799162$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Elisetti, Nirupa</creatorcontrib><title>Extracorporeal shock wave therapy (ESWT): An emerging treatment for peri-implantitis</title><title>Medical hypotheses</title><addtitle>Med Hypotheses</addtitle><description>Implants have captivated dental fraternity with their attractive benefits alongside patient satisfaction. Nonetheless, success rate depends on the durability of implants without persisting symptoms. Many challenges have yet been addressed by the clinicians, be it the patient selection criteria, implant material susceptibility to microbial environment, procedural errors, etc. Evolving techniques focusing on these issues have resolved to a certain extent but research is still progressing towards perfection. ESWT presents itself as a non-invasive treatment modality beneficial both for the patients as well as the clinicians. Focusing on many of its benefits with its antimicrobial function to bone regeneration has attracted us.</description><subject>Anti-Bacterial Agents</subject><subject>Anti-Infective Agents</subject><subject>Biofilms</subject><subject>Bone Regeneration</subject><subject>Dental Implants</subject><subject>Extracorporeal Shockwave Therapy</subject><subject>Growth factors</subject><subject>Humans</subject><subject>Implants</subject><subject>Peri-Implantitis - therapy</subject><issn>0306-9877</issn><issn>1532-2777</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kLtOAzEQRS0EIuHxAxTIZSg2jO3Y3kU0URQeEhIFQZTWxjtLHLIPbAfI37NRgJJqmjNX9x5CzhgMGTB1uRxWuNgMOXA2ZAykknukz6TgCdda75M-CFBJlmrdI0chLAEgG4n0kPSE0FnGFO-T2fQr-tw2vm085isaFo19o5_5B9K4QJ-3GzqYPr3MLq7ouKZYoX919SuNHRwrrCMtG09b9C5xVbvK6-iiCyfkoMxXAU9_7jF5vpnOJnfJw-Pt_WT8kFghVUyQoS65VTKDrr6QhbRyBCkXc0itynLGUyZ4Adpm81TxdJ6NCstKULZUo0KX4pgMdrmtb97XGKKpXLC46npgsw6GS0il6rZCh_Idan0TgsfStN5Vud8YBmZr0yzN1qbZ2jQ7m93T-U_-el5h8ffyq68DrncAdis_HHoTrMPaYuE82miKxv2X_w0BXYUE</recordid><startdate>202105</startdate><enddate>202105</enddate><creator>Elisetti, Nirupa</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202105</creationdate><title>Extracorporeal shock wave therapy (ESWT): An emerging treatment for peri-implantitis</title><author>Elisetti, Nirupa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-e1e7f2c659011035d5c540823b08c69a128132d07c9b8628b94dc1f06cf64d7f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Anti-Bacterial Agents</topic><topic>Anti-Infective Agents</topic><topic>Biofilms</topic><topic>Bone Regeneration</topic><topic>Dental Implants</topic><topic>Extracorporeal Shockwave Therapy</topic><topic>Growth factors</topic><topic>Humans</topic><topic>Implants</topic><topic>Peri-Implantitis - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Elisetti, Nirupa</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Medical hypotheses</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Elisetti, Nirupa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Extracorporeal shock wave therapy (ESWT): An emerging treatment for peri-implantitis</atitle><jtitle>Medical hypotheses</jtitle><addtitle>Med Hypotheses</addtitle><date>2021-05</date><risdate>2021</risdate><volume>150</volume><spage>110565</spage><epage>110565</epage><pages>110565-110565</pages><artnum>110565</artnum><issn>0306-9877</issn><eissn>1532-2777</eissn><abstract>Implants have captivated dental fraternity with their attractive benefits alongside patient satisfaction. Nonetheless, success rate depends on the durability of implants without persisting symptoms. Many challenges have yet been addressed by the clinicians, be it the patient selection criteria, implant material susceptibility to microbial environment, procedural errors, etc. Evolving techniques focusing on these issues have resolved to a certain extent but research is still progressing towards perfection. ESWT presents itself as a non-invasive treatment modality beneficial both for the patients as well as the clinicians. Focusing on many of its benefits with its antimicrobial function to bone regeneration has attracted us.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>33799162</pmid><doi>10.1016/j.mehy.2021.110565</doi><tpages>1</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0306-9877 |
| ispartof | Medical hypotheses, 2021-05, Vol.150, p.110565-110565, Article 110565 |
| issn | 0306-9877 1532-2777 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2508563790 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Anti-Bacterial Agents Anti-Infective Agents Biofilms Bone Regeneration Dental Implants Extracorporeal Shockwave Therapy Growth factors Humans Implants Peri-Implantitis - therapy |
| title | Extracorporeal shock wave therapy (ESWT): An emerging treatment for peri-implantitis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T09%3A48%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Extracorporeal%20shock%20wave%20therapy%20(ESWT):%20An%20emerging%20treatment%20for%20peri-implantitis&rft.jtitle=Medical%20hypotheses&rft.au=Elisetti,%20Nirupa&rft.date=2021-05&rft.volume=150&rft.spage=110565&rft.epage=110565&rft.pages=110565-110565&rft.artnum=110565&rft.issn=0306-9877&rft.eissn=1532-2777&rft_id=info:doi/10.1016/j.mehy.2021.110565&rft_dat=%3Cproquest_cross%3E2508563790%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2508563790&rft_id=info:pmid/33799162&rft_els_id=S0306987721000839&rfr_iscdi=true |